Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10638957 | 0.77 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL2572804 | 0.76 | — | — | |
| SCHEMBL28980630 | 0.76 | — | — | |
| SCHEMBL2572959 | 0.76 | — | — | |
| SCHEMBL11042254 | 0.74 | CYP1A2 (0.38) | CYP1A2OPRM1OPRK1OPRL1 | |
| SCHEMBL11042258 | 0.74 | CYP1A2 (0.38) | CYP1A2OPRM1OPRK1OPRL1 | |
| SCHEMBL17667954 | 0.71 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL7044398 | 0.71 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL8453519 | 0.71 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL10452404 | 0.71 | CYP1A2 (0.32) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030283-B2 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-20050165260-A1 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | VERSUM MATERIALS US, LLC | 2005-07-28 | — | — | US | disclosed |
| EP-1557404-A1 | Process for producing 1,1-Difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165260-A1 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | KMO, KCNB1, KCNB2 | CYP1A2 2721/4885OPRM1 2283/4885OPRK1 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.